Latest GeneXpert MTB/RIF Stories
SUNNYVALE, Calif., March 24, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating
Patients Can Now Be Removed from Respiratory Isolation Following One or Two Negative Xpert MTB/RIF Results SUNNYVALE, Calif., Feb.
NEW YORK, Jan.
Quantitative Test for Rapid Measurement of the HIV-1 Viral Load in Plasma Delivers Individual Results in About 90 Minutes SUNNYVALE, Calif. and GENEVA, Dec.
SUNNYVALE, Calif. and GENEVA, Switzerland, Oct.
First molecular test indicated for samples from both males and females SUNNYVALE, Calif., Sept.
Redundant targets extend coverage to provide detection of seasonal and emerging novel viruses SUNNYVALE, Calif., Sept.
Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic SUNNYVALE, Calif., July 29, 2014 /PRNewswire/ -- With the recent completion of a record shipment of 774 GeneXpert
A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes.
Accurate Norovirus Detection in as Short as One Hour SUNNYVALE, Calif., April 10, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®)